AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
HYDROCHLOROTHIAZIDE; VALSARTAN in Zimbabwe
6 products registered with MCAZ — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| VALSAR HT 160/25 TABLET, COATED; ORAL | 2023/12.3.5/6432 | HETERO LABS LTD | active | 30 Jun 2028 |
| VALSAR HT 80/12.5 TABLET, COATED; ORAL | 2023/12.3.5/6431 | HETERO LABS LTD | active | 30 Jun 2028 |
| CO-DIOVAN TABLET; ORAL | 2016/12.3.5/5190 | NOVARTIS PHARMA SERVICES AG | active | 31 Dec 2027 |
| CO-DIOVAN TABLET; ORAL | 2016/12.3.5/5191 | NOVARTIS PHARMA SERVICES AG | active | 31 Dec 2027 |
| VALMAC H TABLET, COATED; ORAL | 2021/12.3.5/6150 | MACLEODS PHARMACEUTICALS LIMITED | active | 31 Dec 2027 |
| VALMAC H 160 TABLET, COATED; ORAL | 2021/12.3.5/6151 | MACLEODS PHARMACEUTICALS LIMITED | active | 31 Dec 2027 |
HYDROCHLOROTHIAZIDE; VALSARTAN — MCAZ Registration Details
MCAZ (Zimbabwe) has 6 registered products containing HYDROCHLOROTHIAZIDE; VALSARTAN, of which 6 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track HYDROCHLOROTHIAZIDE; VALSARTAN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.